Alafi
Capital is a private venture capital firm that has been active in
healthcare investing for over 25 years. Early and mid-stage investments in the U.S. and Europe are
considered, with emphasis on product-oriented biotechnology, life science
technologies, imaging and diagnostics, and medical devices.
Included among Alafi Capital’s past successes are Amgen, Biogen, Molecular Devices, Tanox, Qiagen, Novocor, Oxford Glycosciences, and Applied Biosystems.